Catalase overexpression fails to attenuate allergic airways disease in the mouse.
Oxidative stress is a hallmark of asthma, and increased levels of oxidants are considered markers of the inflammatory process. Most studies to date addressing the role of oxidants in the etiology of asthma were based on the therapeutic administration of low m.w. antioxidants or antioxidant mimetic compounds. To directly address the function of endogenous hydrogen peroxide in the pathophysiology of allergic airway disease, we comparatively evaluated mice systemically overexpressing catalase, a major antioxidant enzyme that detoxifies hydrogen peroxide, and C57BL/6 strain matched controls in the OVA model of allergic airways disease. Catalase transgenic mice had 8-fold increases in catalase activity in lung tissue, and had lowered DCF oxidation in tracheal epithelial cells, compared with C57BL/6 controls. Despite these differences, both strains showed similar increases in OVA-specific IgE, IgG1, and IgG2a levels, comparable airway and tissue inflammation, and identical increases in procollagen 1 mRNA expression, following sensitization and challenge with OVA. Unexpectedly, mRNA expression of MUC5AC and CLCA3 genes were enhanced in catalase transgenic mice, compared with C57BL/6 mice subjected to Ag. Furthermore, when compared with control mice, catalase overexpression increased airway hyperresponsiveness to methacholine both in naive mice as well as in response to Ag. In contrast to the prevailing notion that hydrogen peroxide is positively associated with the etiology of allergic airways disease, the current findings suggest that endogenous hydrogen peroxide serves a role in suppressing both mucus production and airway hyperresponsiveness.
Reynaert
Niki L
NL
Department of Pathology, University of Vermont, Burlington, VT 05405, USA.
Aesif
Scott W
SW
McGovern
Toby
T
Brown
Amy
A
Wouters
Emiel F M
EF
Irvin
Charles G
CG
Janssen-Heininger
Yvonne M W
YM
D000818:Animals; D001249:Asthma / Q000139:chemically induced / Q000201:enzymology* / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D016085:Bronchoconstrictor Agents / Q000633:toxicity; D002374:Catalase / Q000096:biosynthesis* / Q000235:genetics / Q000276:immunology; D005786:Gene Expression Regulation / Q000235:genetics / Q000276:immunology; D006861:Hydrogen Peroxide / Q000276:immunology / Q000378:metabolism*; D007249:Inflammation / Q000201:enzymology / Q000235:genetics / Q000276:immunology; D018836:Inflammation Mediators / Q000276:immunology / Q000378:metabolism*; D008168:Lung / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D016210:Methacholine Chloride / Q000633:toxicity; D051379:Mice; D008822:Mice, Transgenic; D010047:Ovalbumin / Q000633:toxicity; D018384:Oxidative Stress / Q000235:genetics / Q000276:immunology; D013045:Species Specificity
D016085:Bronchoconstrictor Agents; D018836:Inflammation Mediators; D016210:Methacholine Chloride; D010047:Ovalbumin; D006861:Hydrogen Peroxide; D002374:Catalase